Litcius/Paper detail

COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge

Anthony DiPiazza, Sarah R. Leist, Olubukola M. Abiona, Juan I. Moliva, Anne P. Werner, Mahnaz Minai, Bianca M. Nagata, Kevin W. Bock, Emily Phung, Alexandra Schäfer, Kenneth H. Dinnon, Lauren A. Chang, Rebecca J. Loomis, Seyhan Boyoglu-Barnum, Gabriela Alvarado, Nancy J. Sullivan, Darin K. Edwards, Kaitlyn M. Morabito, John R. Mascola, Andrea Carfı́, Kizzmekia S. Corbett, Ian N. Moore, Ralph S. Baric, Barney S. Graham, Tracy J. Ruckwardt

2021Immunity101 citationsDOIOpen Access PDF

Topics & Concepts

VirologyBiologyImmune systemCoronavirusImmunologyVirusAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Respiratory systemImmunopathologyDiseasePotencyCoronavirus disease 2019 (COVID-19)MedicineInfectious disease (medical specialty)In vitroPathologyAnatomyBiochemistrySARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyAnimal Virus Infections Studies
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge | Litcius